世界のアルコール依存症治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Alcohol Addiction Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3774 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、アルコール依存症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（CM-1212、CTDP-002、A-705253、ABT-436、ADX-71441、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・アルコール依存症治療薬の市場動向 ・企業の競争状況、市場シェア ・アルコール依存症治療薬の種類別市場規模と予測2016-2027（CM-1212、CTDP-002、A-705253、ABT-436、ADX-71441、その他） ・アルコール依存症治療薬の用途別市場規模と予測2016-2027（病院、診療所、その他） ・アルコール依存症治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・アルコール依存症治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・アルコール依存症治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・アルコール依存症治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・アルコール依存症治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AstraZeneca Plc、BioCorRx Inc、Bionex Pharmaceuticals LLC、Cerecor Inc、Chronos Therapeutics Ltd、Corcept Therapeutics Inc、Curemark LLC、Eli Lilly and Company、Ethypharm SA、H. Lundbeck A/S、Heptares Therapeutics Ltd、Indivior Plc、Kinnov Therapeutics SAS、Kyorin Pharmaceutical Co Ltd、Lohocla Research Corp、Montisera Ltd、Omeros Corp、Opiant Pharmaceuticals Inc） ・結論

Market Analysis and Insights: Global Alcohol Addiction Therapeutics Market
The global Alcohol Addiction Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Alcohol Addiction Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Alcohol Addiction Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Alcohol Addiction Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Alcohol Addiction Therapeutics market.

Global Alcohol Addiction Therapeutics Scope and Market Size
Alcohol Addiction Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Alcohol Addiction Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
CM-1212
CTDP-002
A-705253
ABT-436
ADX-71441
Others

Segment by Application
Hospital
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca Plc
BioCorRx Inc
Bionex Pharmaceuticals LLC
Cerecor Inc
Chronos Therapeutics Ltd
Corcept Therapeutics Inc
Curemark LLC
Eli Lilly and Company
Ethypharm SA
H. Lundbeck A/S
Heptares Therapeutics Ltd
Indivior Plc
Kinnov Therapeutics SAS
Kyorin Pharmaceutical Co Ltd
Lohocla Research Corp
Montisera Ltd
Omeros Corp
Opiant Pharmaceuticals Inc

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alcohol Addiction Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 CM-1212
1.2.3 CTDP-002
1.2.4 A-705253
1.2.5 ABT-436
1.2.6 ADX-71441
1.2.7 Others
1.3 Market by Application
1.3.1 Global Alcohol Addiction Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Alcohol Addiction Therapeutics Market Perspective (2016-2027)
2.2 Alcohol Addiction Therapeutics Growth Trends by Regions
2.2.1 Alcohol Addiction Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Alcohol Addiction Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Alcohol Addiction Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Alcohol Addiction Therapeutics Industry Dynamic
2.3.1 Alcohol Addiction Therapeutics Market Trends
2.3.2 Alcohol Addiction Therapeutics Market Drivers
2.3.3 Alcohol Addiction Therapeutics Market Challenges
2.3.4 Alcohol Addiction Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Alcohol Addiction Therapeutics Players by Revenue
3.1.1 Global Top Alcohol Addiction Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Alcohol Addiction Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Alcohol Addiction Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Alcohol Addiction Therapeutics Revenue
3.4 Global Alcohol Addiction Therapeutics Market Concentration Ratio
3.4.1 Global Alcohol Addiction Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alcohol Addiction Therapeutics Revenue in 2020
3.5 Alcohol Addiction Therapeutics Key Players Head office and Area Served
3.6 Key Players Alcohol Addiction Therapeutics Product Solution and Service
3.7 Date of Enter into Alcohol Addiction Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Alcohol Addiction Therapeutics Breakdown Data by Type
4.1 Global Alcohol Addiction Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Alcohol Addiction Therapeutics Forecasted Market Size by Type (2022-2027)

5 Alcohol Addiction Therapeutics Breakdown Data by Application
5.1 Global Alcohol Addiction Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Alcohol Addiction Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Alcohol Addiction Therapeutics Market Size (2016-2027)
6.2 North America Alcohol Addiction Therapeutics Market Size by Type
6.2.1 North America Alcohol Addiction Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Alcohol Addiction Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Alcohol Addiction Therapeutics Market Size by Type (2016-2027)
6.3 North America Alcohol Addiction Therapeutics Market Size by Application
6.3.1 North America Alcohol Addiction Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Alcohol Addiction Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Alcohol Addiction Therapeutics Market Size by Application (2016-2027)
6.4 North America Alcohol Addiction Therapeutics Market Size by Country
6.4.1 North America Alcohol Addiction Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Alcohol Addiction Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Alcohol Addiction Therapeutics Market Size (2016-2027)
7.2 Europe Alcohol Addiction Therapeutics Market Size by Type
7.2.1 Europe Alcohol Addiction Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Alcohol Addiction Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Alcohol Addiction Therapeutics Market Size by Type (2016-2027)
7.3 Europe Alcohol Addiction Therapeutics Market Size by Application
7.3.1 Europe Alcohol Addiction Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Alcohol Addiction Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Alcohol Addiction Therapeutics Market Size by Application (2016-2027)
7.4 Europe Alcohol Addiction Therapeutics Market Size by Country
7.4.1 Europe Alcohol Addiction Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Alcohol Addiction Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Alcohol Addiction Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Alcohol Addiction Therapeutics Market Size by Type
8.2.1 Asia-Pacific Alcohol Addiction Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Alcohol Addiction Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Alcohol Addiction Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Alcohol Addiction Therapeutics Market Size by Application
8.3.1 Asia-Pacific Alcohol Addiction Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Alcohol Addiction Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Alcohol Addiction Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Alcohol Addiction Therapeutics Market Size by Region
8.4.1 Asia-Pacific Alcohol Addiction Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Alcohol Addiction Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Alcohol Addiction Therapeutics Market Size (2016-2027)
9.2 Latin America Alcohol Addiction Therapeutics Market Size by Type
9.2.1 Latin America Alcohol Addiction Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Alcohol Addiction Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Alcohol Addiction Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Alcohol Addiction Therapeutics Market Size by Application
9.3.1 Latin America Alcohol Addiction Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Alcohol Addiction Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Alcohol Addiction Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Alcohol Addiction Therapeutics Market Size by Country
9.4.1 Latin America Alcohol Addiction Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Alcohol Addiction Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Alcohol Addiction Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Alcohol Addiction Therapeutics Market Size by Type
10.2.1 Middle East & Africa Alcohol Addiction Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Alcohol Addiction Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Alcohol Addiction Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Alcohol Addiction Therapeutics Market Size by Application
10.3.1 Middle East & Africa Alcohol Addiction Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Alcohol Addiction Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Alcohol Addiction Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Alcohol Addiction Therapeutics Market Size by Country
10.4.1 Middle East & Africa Alcohol Addiction Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Alcohol Addiction Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca Plc
11.1.1 AstraZeneca Plc Company Details
11.1.2 AstraZeneca Plc Business Overview
11.1.3 AstraZeneca Plc Alcohol Addiction Therapeutics Introduction
11.1.4 AstraZeneca Plc Revenue in Alcohol Addiction Therapeutics Business (2016-2021)
11.1.5 AstraZeneca Plc Recent Development
11.2 BioCorRx Inc
11.2.1 BioCorRx Inc Company Details
11.2.2 BioCorRx Inc Business Overview
11.2.3 BioCorRx Inc Alcohol Addiction Therapeutics Introduction
11.2.4 BioCorRx Inc Revenue in Alcohol Addiction Therapeutics Business (2016-2021)
11.2.5 BioCorRx Inc Recent Development
11.3 Bionex Pharmaceuticals LLC
11.3.1 Bionex Pharmaceuticals LLC Company Details
11.3.2 Bionex Pharmaceuticals LLC Business Overview
11.3.3 Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Introduction
11.3.4 Bionex Pharmaceuticals LLC Revenue in Alcohol Addiction Therapeutics Business (2016-2021)
11.3.5 Bionex Pharmaceuticals LLC Recent Development
11.4 Cerecor Inc
11.4.1 Cerecor Inc Company Details
11.4.2 Cerecor Inc Business Overview
11.4.3 Cerecor Inc Alcohol Addiction Therapeutics Introduction
11.4.4 Cerecor Inc Revenue in Alcohol Addiction Therapeutics Business (2016-2021)
11.4.5 Cerecor Inc Recent Development
11.5 Chronos Therapeutics Ltd
11.5.1 Chronos Therapeutics Ltd Company Details
11.5.2 Chronos Therapeutics Ltd Business Overview
11.5.3 Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Introduction
11.5.4 Chronos Therapeutics Ltd Revenue in Alcohol Addiction Therapeutics Business (2016-2021)
11.5.5 Chronos Therapeutics Ltd Recent Development
11.6 Corcept Therapeutics Inc
11.6.1 Corcept Therapeutics Inc Company Details
11.6.2 Corcept Therapeutics Inc Business Overview
11.6.3 Corcept Therapeutics Inc Alcohol Addiction Therapeutics Introduction
11.6.4 Corcept Therapeutics Inc Revenue in Alcohol Addiction Therapeutics Business (2016-2021)
11.6.5 Corcept Therapeutics Inc Recent Development
11.7 Curemark LLC
11.7.1 Curemark LLC Company Details
11.7.2 Curemark LLC Business Overview
11.7.3 Curemark LLC Alcohol Addiction Therapeutics Introduction
11.7.4 Curemark LLC Revenue in Alcohol Addiction Therapeutics Business (2016-2021)
11.7.5 Curemark LLC Recent Development
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Company Details
11.8.2 Eli Lilly and Company Business Overview
11.8.3 Eli Lilly and Company Alcohol Addiction Therapeutics Introduction
11.8.4 Eli Lilly and Company Revenue in Alcohol Addiction Therapeutics Business (2016-2021)
11.8.5 Eli Lilly and Company Recent Development
11.9 Ethypharm SA
11.9.1 Ethypharm SA Company Details
11.9.2 Ethypharm SA Business Overview
11.9.3 Ethypharm SA Alcohol Addiction Therapeutics Introduction
11.9.4 Ethypharm SA Revenue in Alcohol Addiction Therapeutics Business (2016-2021)
11.9.5 Ethypharm SA Recent Development
11.10 H. Lundbeck A/S
11.10.1 H. Lundbeck A/S Company Details
11.10.2 H. Lundbeck A/S Business Overview
11.10.3 H. Lundbeck A/S Alcohol Addiction Therapeutics Introduction
11.10.4 H. Lundbeck A/S Revenue in Alcohol Addiction Therapeutics Business (2016-2021)
11.10.5 H. Lundbeck A/S Recent Development
11.11 Heptares Therapeutics Ltd
11.11.1 Heptares Therapeutics Ltd Company Details
11.11.2 Heptares Therapeutics Ltd Business Overview
11.11.3 Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Introduction
11.11.4 Heptares Therapeutics Ltd Revenue in Alcohol Addiction Therapeutics Business (2016-2021)
11.11.5 Heptares Therapeutics Ltd Recent Development
11.12 Indivior Plc
11.12.1 Indivior Plc Company Details
11.12.2 Indivior Plc Business Overview
11.12.3 Indivior Plc Alcohol Addiction Therapeutics Introduction
11.12.4 Indivior Plc Revenue in Alcohol Addiction Therapeutics Business (2016-2021)
11.12.5 Indivior Plc Recent Development
11.13 Kinnov Therapeutics SAS
11.13.1 Kinnov Therapeutics SAS Company Details
11.13.2 Kinnov Therapeutics SAS Business Overview
11.13.3 Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Introduction
11.13.4 Kinnov Therapeutics SAS Revenue in Alcohol Addiction Therapeutics Business (2016-2021)
11.13.5 Kinnov Therapeutics SAS Recent Development
11.14 Kyorin Pharmaceutical Co Ltd
11.14.1 Kyorin Pharmaceutical Co Ltd Company Details
11.14.2 Kyorin Pharmaceutical Co Ltd Business Overview
11.14.3 Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Introduction
11.14.4 Kyorin Pharmaceutical Co Ltd Revenue in Alcohol Addiction Therapeutics Business (2016-2021)
11.14.5 Kyorin Pharmaceutical Co Ltd Recent Development
11.15 Lohocla Research Corp
11.15.1 Lohocla Research Corp Company Details
11.15.2 Lohocla Research Corp Business Overview
11.15.3 Lohocla Research Corp Alcohol Addiction Therapeutics Introduction
11.15.4 Lohocla Research Corp Revenue in Alcohol Addiction Therapeutics Business (2016-2021)
11.15.5 Lohocla Research Corp Recent Development
11.16 Montisera Ltd
11.16.1 Montisera Ltd Company Details
11.16.2 Montisera Ltd Business Overview
11.16.3 Montisera Ltd Alcohol Addiction Therapeutics Introduction
11.16.4 Montisera Ltd Revenue in Alcohol Addiction Therapeutics Business (2016-2021)
11.16.5 Montisera Ltd Recent Development
11.17 Omeros Corp
11.17.1 Omeros Corp Company Details
11.17.2 Omeros Corp Business Overview
11.17.3 Omeros Corp Alcohol Addiction Therapeutics Introduction
11.17.4 Omeros Corp Revenue in Alcohol Addiction Therapeutics Business (2016-2021)
11.17.5 Omeros Corp Recent Development
11.18 Opiant Pharmaceuticals Inc
11.18.1 Opiant Pharmaceuticals Inc Company Details
11.18.2 Opiant Pharmaceuticals Inc Business Overview
11.18.3 Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Introduction
11.18.4 Opiant Pharmaceuticals Inc Revenue in Alcohol Addiction Therapeutics Business (2016-2021)
11.18.5 Opiant Pharmaceuticals Inc Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Alcohol Addiction Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of CM-1212
Table 3. Key Players of CTDP-002
Table 4. Key Players of A-705253
Table 5. Key Players of ABT-436
Table 6. Key Players of ADX-71441
Table 7. Key Players of Others
Table 8. Global Alcohol Addiction Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Alcohol Addiction Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Alcohol Addiction Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Alcohol Addiction Therapeutics Market Share by Regions (2016-2021)
Table 12. Global Alcohol Addiction Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Alcohol Addiction Therapeutics Market Share by Regions (2022-2027)
Table 14. Alcohol Addiction Therapeutics Market Trends
Table 15. Alcohol Addiction Therapeutics Market Drivers
Table 16. Alcohol Addiction Therapeutics Market Challenges
Table 17. Alcohol Addiction Therapeutics Market Restraints
Table 18. Global Alcohol Addiction Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Alcohol Addiction Therapeutics Market Share by Players (2016-2021)
Table 20. Global Top Alcohol Addiction Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alcohol Addiction Therapeutics as of 2020)
Table 21. Ranking of Global Top Alcohol Addiction Therapeutics Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Alcohol Addiction Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Alcohol Addiction Therapeutics Product Solution and Service
Table 25. Date of Enter into Alcohol Addiction Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Alcohol Addiction Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Alcohol Addiction Therapeutics Revenue Market Share by Type (2016-2021)
Table 29. Global Alcohol Addiction Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Alcohol Addiction Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Alcohol Addiction Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Alcohol Addiction Therapeutics Revenue Market Share by Application (2016-2021)
Table 33. Global Alcohol Addiction Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Alcohol Addiction Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Alcohol Addiction Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Alcohol Addiction Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Alcohol Addiction Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Alcohol Addiction Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Alcohol Addiction Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Alcohol Addiction Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Alcohol Addiction Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Alcohol Addiction Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Alcohol Addiction Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Alcohol Addiction Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Alcohol Addiction Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Alcohol Addiction Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Alcohol Addiction Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Alcohol Addiction Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Alcohol Addiction Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Alcohol Addiction Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Alcohol Addiction Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Alcohol Addiction Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Alcohol Addiction Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Alcohol Addiction Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Alcohol Addiction Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Alcohol Addiction Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Alcohol Addiction Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Alcohol Addiction Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Alcohol Addiction Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Alcohol Addiction Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Alcohol Addiction Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Alcohol Addiction Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Alcohol Addiction Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Alcohol Addiction Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 65. AstraZeneca Plc Company Details
Table 66. AstraZeneca Plc Business Overview
Table 67. AstraZeneca Plc Alcohol Addiction Therapeutics Product
Table 68. AstraZeneca Plc Revenue in Alcohol Addiction Therapeutics Business (2016-2021) & (US$ Million)
Table 69. AstraZeneca Plc Recent Development
Table 70. BioCorRx Inc Company Details
Table 71. BioCorRx Inc Business Overview
Table 72. BioCorRx Inc Alcohol Addiction Therapeutics Product
Table 73. BioCorRx Inc Revenue in Alcohol Addiction Therapeutics Business (2016-2021) & (US$ Million)
Table 74. BioCorRx Inc Recent Development
Table 75. Bionex Pharmaceuticals LLC Company Details
Table 76. Bionex Pharmaceuticals LLC Business Overview
Table 77. Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Product
Table 78. Bionex Pharmaceuticals LLC Revenue in Alcohol Addiction Therapeutics Business (2016-2021) & (US$ Million)
Table 79. Bionex Pharmaceuticals LLC Recent Development
Table 80. Cerecor Inc Company Details
Table 81. Cerecor Inc Business Overview
Table 82. Cerecor Inc Alcohol Addiction Therapeutics Product
Table 83. Cerecor Inc Revenue in Alcohol Addiction Therapeutics Business (2016-2021) & (US$ Million)
Table 84. Cerecor Inc Recent Development
Table 85. Chronos Therapeutics Ltd Company Details
Table 86. Chronos Therapeutics Ltd Business Overview
Table 87. Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Product
Table 88. Chronos Therapeutics Ltd Revenue in Alcohol Addiction Therapeutics Business (2016-2021) & (US$ Million)
Table 89. Chronos Therapeutics Ltd Recent Development
Table 90. Corcept Therapeutics Inc Company Details
Table 91. Corcept Therapeutics Inc Business Overview
Table 92. Corcept Therapeutics Inc Alcohol Addiction Therapeutics Product
Table 93. Corcept Therapeutics Inc Revenue in Alcohol Addiction Therapeutics Business (2016-2021) & (US$ Million)
Table 94. Corcept Therapeutics Inc Recent Development
Table 95. Curemark LLC Company Details
Table 96. Curemark LLC Business Overview
Table 97. Curemark LLC Alcohol Addiction Therapeutics Product
Table 98. Curemark LLC Revenue in Alcohol Addiction Therapeutics Business (2016-2021) & (US$ Million)
Table 99. Curemark LLC Recent Development
Table 100. Eli Lilly and Company Company Details
Table 101. Eli Lilly and Company Business Overview
Table 102. Eli Lilly and Company Revenue in Alcohol Addiction Therapeutics Business (2016-2021) & (US$ Million)
Table 103. Eli Lilly and Company Recent Development
Table 104. Ethypharm SA Company Details
Table 105. Ethypharm SA Business Overview
Table 106. Ethypharm SA Alcohol Addiction Therapeutics Product
Table 107. Ethypharm SA Revenue in Alcohol Addiction Therapeutics Business (2016-2021) & (US$ Million)
Table 108. Ethypharm SA Recent Development
Table 109. H. Lundbeck A/S Company Details
Table 110. H. Lundbeck A/S Business Overview
Table 111. H. Lundbeck A/S Alcohol Addiction Therapeutics Product
Table 112. H. Lundbeck A/S Revenue in Alcohol Addiction Therapeutics Business (2016-2021) & (US$ Million)
Table 113. H. Lundbeck A/S Recent Development
Table 114. Heptares Therapeutics Ltd Company Details
Table 115. Heptares Therapeutics Ltd Business Overview
Table 116. Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Product
Table 117. Heptares Therapeutics Ltd Revenue in Alcohol Addiction Therapeutics Business (2016-2021) & (US$ Million)
Table 118. Heptares Therapeutics Ltd Recent Development
Table 119. Indivior Plc Company Details
Table 120. Indivior Plc Business Overview
Table 121. Indivior Plc Alcohol Addiction Therapeutics Product
Table 122. Indivior Plc Revenue in Alcohol Addiction Therapeutics Business (2016-2021) & (US$ Million)
Table 123. Indivior Plc Recent Development
Table 124. Kinnov Therapeutics SAS Company Details
Table 125. Kinnov Therapeutics SAS Business Overview
Table 126. Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Product
Table 127. Kinnov Therapeutics SAS Revenue in Alcohol Addiction Therapeutics Business (2016-2021) & (US$ Million)
Table 128. Kinnov Therapeutics SAS Recent Development
Table 129. Kyorin Pharmaceutical Co Ltd Company Details
Table 130. Kyorin Pharmaceutical Co Ltd Business Overview
Table 131. Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Product
Table 132. Kyorin Pharmaceutical Co Ltd Revenue in Alcohol Addiction Therapeutics Business (2016-2021) & (US$ Million)
Table 133. Kyorin Pharmaceutical Co Ltd Recent Development
Table 134. Lohocla Research Corp Company Details
Table 135. Lohocla Research Corp Business Overview
Table 136. Lohocla Research Corp Alcohol Addiction Therapeutics Product
Table 137. Lohocla Research Corp Revenue in Alcohol Addiction Therapeutics Business (2016-2021) & (US$ Million)
Table 138. Lohocla Research Corp Recent Development
Table 139. Montisera Ltd Company Details
Table 140. Montisera Ltd Business Overview
Table 141. Montisera Ltd Alcohol Addiction Therapeutics Product
Table 142. Montisera Ltd Revenue in Alcohol Addiction Therapeutics Business (2016-2021) & (US$ Million)
Table 143. Montisera Ltd Recent Development
Table 144. Omeros Corp Company Details
Table 145. Omeros Corp Business Overview
Table 146. Omeros Corp Alcohol Addiction Therapeutics Product
Table 147. Omeros Corp Revenue in Alcohol Addiction Therapeutics Business (2016-2021) & (US$ Million)
Table 148. Omeros Corp Recent Development
Table 149. Opiant Pharmaceuticals Inc Company Details
Table 150. Opiant Pharmaceuticals Inc Business Overview
Table 151. Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Product
Table 152. Opiant Pharmaceuticals Inc Revenue in Alcohol Addiction Therapeutics Business (2016-2021) & (US$ Million)
Table 153. Opiant Pharmaceuticals Inc Recent Development
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alcohol Addiction Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. CM-1212 Features
Figure 3. CTDP-002 Features
Figure 4. A-705253 Features
Figure 5. ABT-436 Features
Figure 6. ADX-71441 Features
Figure 7. Others Features
Figure 8. Global Alcohol Addiction Therapeutics Market Share by Application: 2020 VS 2027
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Alcohol Addiction Therapeutics Report Years Considered
Figure 13. Global Alcohol Addiction Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Alcohol Addiction Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Alcohol Addiction Therapeutics Market Share by Regions: 2020 VS 2027
Figure 16. Global Alcohol Addiction Therapeutics Market Share by Regions (2022-2027)
Figure 17. Global Alcohol Addiction Therapeutics Market Share by Players in 2020
Figure 18. Global Top Alcohol Addiction Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alcohol Addiction Therapeutics as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Alcohol Addiction Therapeutics Revenue in 2020
Figure 20. Global Alcohol Addiction Therapeutics Revenue Market Share by Type (2016-2021)
Figure 21. Global Alcohol Addiction Therapeutics Revenue Market Share by Type (2022-2027)
Figure 22. North America Alcohol Addiction Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Alcohol Addiction Therapeutics Market Share by Type (2016-2027)
Figure 24. North America Alcohol Addiction Therapeutics Market Share by Application (2016-2027)
Figure 25. North America Alcohol Addiction Therapeutics Market Share by Country (2016-2027)
Figure 26. United States Alcohol Addiction Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Alcohol Addiction Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Alcohol Addiction Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Alcohol Addiction Therapeutics Market Share by Type (2016-2027)
Figure 30. Europe Alcohol Addiction Therapeutics Market Share by Application (2016-2027)
Figure 31. Europe Alcohol Addiction Therapeutics Market Share by Country (2016-2027)
Figure 32. Germany Alcohol Addiction Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Alcohol Addiction Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Alcohol Addiction Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Alcohol Addiction Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Alcohol Addiction Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Alcohol Addiction Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Alcohol Addiction Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Alcohol Addiction Therapeutics Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Alcohol Addiction Therapeutics Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Alcohol Addiction Therapeutics Market Share by Region (2016-2027)
Figure 42. China Alcohol Addiction Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Alcohol Addiction Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Alcohol Addiction Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Alcohol Addiction Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Alcohol Addiction Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Alcohol Addiction Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Alcohol Addiction Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Alcohol Addiction Therapeutics Market Share by Type (2016-2027)
Figure 50. Latin America Alcohol Addiction Therapeutics Market Share by Application (2016-2027)
Figure 51. Latin America Alcohol Addiction Therapeutics Market Share by Country (2016-2027)
Figure 52. Mexico Alcohol Addiction Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Alcohol Addiction Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Alcohol Addiction Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Alcohol Addiction Therapeutics Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Alcohol Addiction Therapeutics Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Alcohol Addiction Therapeutics Market Share by Country (2016-2027)
Figure 58. Turkey Alcohol Addiction Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Alcohol Addiction Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Alcohol Addiction Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. AstraZeneca Plc Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2016-2021)
Figure 62. BioCorRx Inc Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2016-2021)
Figure 63. Bionex Pharmaceuticals LLC Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2016-2021)
Figure 64. Cerecor Inc Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2016-2021)
Figure 65. Chronos Therapeutics Ltd Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2016-2021)
Figure 66. Corcept Therapeutics Inc Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2016-2021)
Figure 67. Curemark LLC Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2016-2021)
Figure 68. Eli Lilly and Company Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2016-2021)
Figure 69. Ethypharm SA Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2016-2021)
Figure 70. H. Lundbeck A/S Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2016-2021)
Figure 71. Heptares Therapeutics Ltd Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2016-2021)
Figure 72. Indivior Plc Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2016-2021)
Figure 73. Kinnov Therapeutics SAS Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2016-2021)
Figure 74. Kyorin Pharmaceutical Co Ltd Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2016-2021)
Figure 75. Lohocla Research Corp Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2016-2021)
Figure 76. Montisera Ltd Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2016-2021)
Figure 77. Omeros Corp Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2016-2021)
Figure 78. Opiant Pharmaceuticals Inc Revenue Growth Rate in Alcohol Addiction Therapeutics Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed

---